Gabriela Hobbs/Massachusetts General Hospital
Sep 13, 2026, 04:22
Gabriela Hobbs: 2026 Society of Hematologic Oncology Meeting
Gabriela Hobbs, Leukemia Clinical Director at Massachusetts General Hospital, Associate Professor at Harvard Medical School shared a post on LinkedIn:
“Great Society of Hematologic Oncology 2026 meeting!
Excited to present on updates in ET and PV, including two newly approved drugs!
Had a great time leading the MPN poster walk and so proud of my mentee and fellow, Kate Feder for her poster describing the MGB experience with ropeg.”
Stay updated with Hemostasis Today.
-
Sep 13, 2026, 03:40Mizinga Moonze: When Blood Speaks – The Missing Link in Healthcare Sustainability
-
Sep 12, 2026, 17:55Dries De Wolf: Honored to Have Wolfgang Miesbach Comment on Our Latest Research
-
Sep 12, 2026, 17:53Usman Waheed: Introducing the Discovery of the 49th ISBT Blood Group System
-
Sep 12, 2026, 17:51Maria Sabater Lleal: Happy to Share Our Latest Work Exploring the Genetic Determinants of PE in VTE
-
Sep 12, 2026, 17:51Jeff Sternlicht: Why LDL-C and ApoB Remain King of the Hill?
-
Sep 12, 2026, 17:49Kalyan Roy: TRAGS – An Emerging Transfusion Safety Concern
-
Sep 12, 2026, 17:48Jason Fung: What Happened to “Statins Save Lives”?
-
Sep 12, 2026, 17:47Eric Topol: Most Supplements and Vitamins Offer Little Proven Benefit
-
Sep 12, 2026, 17:44Manuel Monreal: Clinical Characteristics, Treatment, and Outcomes in Hispanic vs Caucasian Patients With VTE